• Tue, April 16, 2024
Andrew Fein Maintained (UBX) at Strong Buy with Decreased Target to $8 on, Apr 16th, 2024
Andrew Fein of HC Wainwright & Co., Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Decreased Target from $10 to $8 on, Apr 16th, 2024.
Andrew, nor any peers, have made any analyst calls on UBX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
WOPRAI
Market Predictions Driven by AI
- Website: https://www.woprai.com/
- Email: support@woprai.com